Re-assessing the diagnostic value of the enhancing capsule in hepatocellular carcinoma imaging.

ABSTRACT:

Backgrounds/aims

The enhancing capsule (EC) in hepatocellular carcinoma (HCC) diagnosis has received varying degrees of recognition across major guidelines. This study aimed to assess the diagnostic utility of EC in HCC detection.

Methods

We retrospectively analyzed patients who underwent pre-surgical computed tomography (CT) and hepatobiliary agent-enhanced magnetic resonance imaging (HBA-MRI) between January 2016 and December 2019. A single hepatic tumor was confirmed based on the pathology of each patient. Three radiologists independently reviewed the images according to the Liver Imaging Reporting and Data System (LI-RADS) v2018 criteria and reached a consensus. Interobserver agreement for EC before reaching a consensus was quantified using Fleiss κ statistics. The impac

SUBMITTER: Bae JS 

PROVIDER: S-EPMC11449579 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature